News
Bayer and Kumquat Biosciences have entered an exclusive global license and collaboration to develop and commercialize Kumquat ...
Avista will leverage Forge’s FUEL platform to manufacture AAV for AVST-101, Avista’s lead gene therapy to treat patients with X-linked retinoschisis (XLRS).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback